The Gilead pact signed between Jubilant Life Sciences' subsidiary Jubilant Generics Ltd and Gilead, will grant the former the right to register, manufacture and sell the latter's investigation drug, remdesivir - a potential therapy for Covid-19.
from Top Business News- News18.com https://ift.tt/2SYVsfA
Home
Top Business News- News18.com
Jubilant Life Sciences Shares Jump Five Percent on Gilead Pact for Covid-19 Therapy Drug
0 comments: